Pattern of Drug Sales at Community Pharmacies in Edo State as Evidence of Self-medication during the COVID-19 Pandemic: Implications for Policy Implementation

Authors

  • Iriagbonse Iyabo Osaigbovo Department of Medical Microbiology, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State, Nigeria
  • Esohe Olivia Ogboghodo Department of Community Health University of Benin Teaching Hospital Benin City Edo State
  • Darlington Ewaen Obaseki Department of Anatomic Pathology, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State
  • Obehi Akoria Department of Medicine, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State
  • Ewere Scholastica Ehinze Department of Community Health, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State
  • Otaniyenuwa Eloghosa Obarisiagbon Department of Community Health, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State
  • Obiageli Henrietta Nneka Okwara Department of Community Health, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State

DOI:

https://doi.org/10.60787/tnhj.v20i4.499

Keywords:

Self-medication, COVID-19, community pharmacists, Benin City

Abstract

Background: Inappropriate self-medication, recognized as one of the indirect health effects of the COVID-19 pandemic, is especially worrisome because of reported toxicity and unproven efficacy of various drug combinations touted as cures for the disease. Little scientific documentation exists on the range of drugs being self-medicated during the pandemic in Nigeria. This study assessed the pattern of drug sales at community pharmacies during the COVID-19 pandemic to ascertain the drugs commonly used for self-medication.

Methods: A descriptive cross-sectional study was conducted across community pharmacies in Benin City, Edo state in June 2020 to assess the pattern of sales of drugs. Data was collected using a self-administered questionnaire and a record review of medication sales carried out to compare sales in the 1st and 2nd quarters of 2020. Data were analyzed using IBM-SPSS version 25.0.

Results: Sixty-two community pharmacies were assessed. Of these, record review showed an increase in sales in the 2nd Quarter, compared to the 1st  quarter, of Hydroxychloroquine 62 (100.0%), Chloroquine 51 (82.3%),  vitamin C 62 (100.0%) and immune boosters 61 (98.4%). Forty-one (66.1%) community pharmacies reported an increase in sales of Azithromycin and Zinc respectively and 27 (43.5%) reported an increase in the sales of Artemisinin-based combination therapy. Prescription sheets were not mandatory for the sales of these medications in any of the pharmacies.

Conclusion: There was an increase in sales of antimalaria, antibiotics, and multivitamins reported to be useful in the management of COVID-19 without prescription. Implementation of drug policies is necessary to guarantee public safety.

Author Biographies

Iriagbonse Iyabo Osaigbovo, Department of Medical Microbiology, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State, Nigeria

Senior lecturer in Department of Medical Microbiology, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State, Nigeria

Esohe Olivia Ogboghodo, Department of Community Health University of Benin Teaching Hospital Benin City Edo State

Senior Lecturer in Department of Community Health, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State

Darlington Ewaen Obaseki, Department of Anatomic Pathology, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State

Professor of Anatomic Pathology, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State

Obehi Akoria, Department of Medicine, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State

Professor of Medicine, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State.

Otaniyenuwa Eloghosa Obarisiagbon, Department of Community Health, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State

Senior Lecturer in Department of Community Health, University of Benin Teaching Hospital, Benin City, PMB 1111, Edo State

References

El Bcheraoui, C., Weishaar, H., Pozo-Martin, F. et al. Assessing COVID-19 through the lens of health systems’ preparedness: time for a change. Global Health 2020; 16: 112. https://doi.org/10.1186/s12992-020-00645-5

World Health Organisation. Weekly epidemiological update - 17 November 2020 Available at https://www.who.int/publications/m/item/weekly-epidemiological-update---17-november-2020 (Accessed on November 20, 2020)

Elston JWT, Cartwright C, Ndumbi P, Wright J. The health impact of the 2014-15 Ebola outbreak. Public Health 2017;143: 60-70

Migliori GB, Thong PM, Akkerman O, Alffenaar J, Álvarez-Navascués F, Assao-Neino MM et al. Worldwide effects of coronavirus disease pandemic on tuberculosis services, January-April 2020. Emerg Infect Dis 2020; 26(11): 2709-2712

Roberton T, Carter ED, Chou VB, Stegmuller AR, Jackson BD, Tam Y et al. Early estimates of the indirect effect of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8: e901-e908

Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N et al. The psychological impact of quarantine and how to reduce it: a rapid review of the evidence. Lancet 2020; 395: 912-920

Zaami S, Marinelli E, Vari MR. New trends of substance abuse during COVID-19 pandemic: an international perspective. Front Psychiatry 2020; 11: 700. doi:10.1097/ADM.000000000000685

World Health Organisation. Guidelines for the regulatory assessment of medical products for use in self-medication. Geneva: World Health Organisation; 2000

Eticha T, Mesfin K. Self-medication practices in Mekelle, Ethiopia. PLoS One 2014; 9(5): e97464

Alghanim S.A. Self-medication practice among patients in a public health care system. Eastern Mediterrenean Health Journal. 2011;17(5): 409 – 416

Limaye D, Limaye V.., Krause G., Fortwengel G. A systematic review of the literature to assess self-medication practices. Ann Med Health Sci Res. 2017; 7: 1-15.

Esan D.T., Fasoro A.A., Odesanya O.E., Esan T.O., Ojo E.F., Faeji C.O. Assessment of self-medication practices and its associated factors among undergraduates of a private university in Nigeria. J Environ Public Health. 2018; 2018: 5439079 Available from: https://doi.org/10.1155/2018/5439079

Malik M, Tahir MJ, Jabbar R, Ahmed A, Hussain R. Self-medication during COVID-19 pandemic: challenges and opportunities. Drug Ther Perspect 2020; 36: 565-567

Mudenda S, Witika BA, Sadiq MJ, Banda M, Mfune RL, Daka V et al. Self-medication and its consequences during and after the coronavirus disease 2019 (COVID-19) pandemic: a global health problem. Europ J Environ Public Health 2020: 5(1): em0066

Onchonga D, Omwoyo J, Nyamamba D. Assessing the prevalence of self-medication among healthcare workers before and during the 2019 SARS-CoV-2 (COVID-19) pandemic in Kenya. Saudi Pharmaceutial Journal 2020; 28(10): 1149-1154

Islam MS, Sarkar T, Khan SH, Mostofa Kamal AH, Hasan SMM, Kabir A. COVID-19 related infodemic and its impact on public health: a global social media analysis. AJTMH 2020; 103(4): 1621-1629

Mallhi TH, Khan YH, Alotaibi NH, Alzarea AI, Alanazi AS, Qasim S, Iqbal MS, Tanveer N. Drug repurposing for COVID-19: a potential threat of self-medication and controlling measures. Postgrad Med J. 2020 Aug 26:postgradmedj-2020-138447. doi: 10.1136/postgradmedj-2020-138447. Epub ahead of print. PMID: 32848085; PMCID: PMC7448118.

World Health Organization. Coronavirus disease (COVID-19) advice for the public: mythbusters. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters. Accessed 6 Sep 2020

Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG et al. Effects of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial. JAMA 2020; 324(21): 2165-2176.

Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR et al. Effects of Hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 2020; 383(21): 2030-2040

Cavalcanti AB, Zampieri F, Rosa RG, Azevedo LCP, Veiga VC, Avezum A et al. Hydroxychloroquine with or without Azithromycin in mild to moderate Covid-19. N Engl J Med 2020; 383(21): 2041-2052

Rajasingham R, Bangdiwala AS, Nicol MR, Skipper CP, Pastick KA, Axelrod ML et al. Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial. Clin Infect Dis 2020; ciaa1571. https://doi.org/10.1093/cid/ciaa1571

Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med 2020; 383: 517-525

Herb F Sewell, Raymond M Agius, Denise Kendrick, Marcia Stewart. Covid-19 vaccines: delivering protective immunity. BMJ 2020; 371:m4838.

Sadio AJ, Gbeasor-Komlanvi FA, Konu RY, Bakoubayi AW, Tchankoni MK, Bitty-Anderson A et al. Assessment of self-medication practices in the context of COVID-19 outbreak in Togo. Research Square preprint 2020

Wegbom AI, Edet CK, Raimi O, Fagbamigbe AF, Kiri VA. Self-medication practices and associated factors in the prevention and/or treatment of COVID-19 virus: a population-based survey in Nigeria. Research square preprint 2020. https://doi.org/10.21203/rs.3.rs-91101/v1

Nasir M, Chowdhury AS, Zahan T. Self-medication during the COVID-19 outbreak: a cross-sectional online survey in Dhaka city. Int J of Basic Clin Pharmacol 2020; 9(9): 1325-1330

Obaseki DE, Akoria O, Ogboghodo EO, Obarisiagbon OE, Mokogwu N, Omo-Ikirodah OT et al . Mainstreaming the private health sector in the response to COVID-19: facility readiness assessment for screening services in Edo state, Nigeria. PAMJ 2020 35: 93. doi: 10.11604/pamj.supp.2020.35.2.24468.

Edo State Government. About Edo State. Accessed 24 April 2020.

Oparah AC, Arigbe-Osula EM. Evaluation of community pharmacists’ involvement in primary health care. Trop J Pharm Res 2002; 1 (2): 67-74

Obaseki DE, Akoria OA, Mokogwu N, Omuemu CE, Okwara BU, Ogboghodo EO, 2020. Staff risks stratification in preparation for COVID-19 in a tertiary healthcare facility in Nigeria. PAMJ 35: 124. Doi:10.11604/pamj.supp.2020.35.2.25095

Nigeria Centre for Disease Control (NCDC). COVID 19 progression. Available at https://covid19.ncdc.gov.ng/progression/. Accessed 26th August, 2020

Lane JCE, Weaver J, Kostka K, Duarte-Salles T, Abrahao MT, Alghoul H et al. Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol 2020; 2(11): e698-e711

Mehta B, Salmon J, Ibrahim S. Potential shortages of hydroxychloroquine for patients with lupus during the coronavirus disease 2019 pandemic. JAMA Health Forum. 2020. https://doi.org/10.1001/jamahealthforum.2020.0438

Hedima EW, Adeyemi MS, Ikunaiye NY. Community Pharmacists: On the frontline of health service against COVID-19 in LMICs. Res Social and Adm Pharm. 2021; 17(1): 1964-1966. doi:10.1016/j.sapharm.2020.04.013

Ahmad A, Alkharfy KM, Alrabiah Z, Alhossan A. Saudi Arabia, pharmacists and COVID-19 pandemic. J Pharm Policy Pract 2020; 13: 41

Downloads

Published

2021-03-28

How to Cite

Osaigbovo, I. I., Ogboghodo, E. O., Obaseki, D. E., Akoria, O., Ehinze, E. S., Obarisiagbon, O. E., & Okwara, O. H. N. (2021). Pattern of Drug Sales at Community Pharmacies in Edo State as Evidence of Self-medication during the COVID-19 Pandemic: Implications for Policy Implementation. The Nigerian Health Journal, 20(4), 150–158. https://doi.org/10.60787/tnhj.v20i4.499

Most read articles by the same author(s)

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.